Table 3.
Summary of the TROP2 Relative Expression Levels, IC50 and Imax Values of Diverse BC Cell Lines
| Cell | Subtype | TROP2 Relative Expression | IC50 (nM) | Imax (%) | ||
|---|---|---|---|---|---|---|
| MMAE | DS001 | MMAE | DS001 | |||
| MDA-MB-468 | TNBC | 57098 | 0.1102 | 0.3019 | 67.35 | 66.65 |
| SK-BR-3 | HER2+ | 48,206 | 0.0489 | 0.0245 | 75.64 | 74.83 |
| MCF-10A | Fibroadenoma | 41,671 | 0.3391 | 0.47 | 82.22 | 64.33 |
| MCF7 | Luminal A | 30490 | 1.592 | 0.4261 | 61.63 | 27.25 |
| HCC1806 | TNBC | 19182 | 0.0958 | 0.2512 | 74.46 | 71.31 |
| MDA-MB-231 | TNBC | 5718 | 0.3787 | 145 | 61.99 | 59.68 |
| MDA-MB-453 | TNBC | 1971 | 0.0715 | 117.5 | 65.75 | 55.64 |
| SUM159 | TNBC | 7 | 0.5506 | >300 | 75.42 | −26.1 |
Abbreviations: BC, breast cancer; MMAE, monomethyl auristatin E; IC50, half maximal inhibitory concentration; Imax, maximal inhibition rate.